| 臺大學術典藏 |
2018-09-10T18:06:52Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai, M.-S. and Chang, S.-Y. and Lin, S.-W. and Kuo, C.-H. and Sun, H.-Y. and Wu, B.-R. and Tang, S.-Y. and Liu, W.-C. and Su, Y.-C. and Hung, C.-C. and Chang, S.-C.; CHING-HUA KUO; SHAN-CHWEN CHANG; HSIN-YUN SUN |
| 臺大學術典藏 |
2020-03-09T06:08:10Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Chang S.-Y.;Shu-Wen Lin;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2017 |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Wu B.-R.; Tang S.-Y.; HSIN-YUN SUN; Kuo C.-H.; Lin S.-W.; Chang S.-Y.; Tsai M.-S.; Chang S.-C.; Hung C.-C.; Liu W.-C.; Su Y.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:13Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Chang S.-Y.;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Shan-Chwen Chang; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-06-04T06:23:11Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:18Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 國立成功大學 |
2024 |
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination with Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection among People with HIV
|
Lin;K, -Y.;Sun;H, -Y.;Yang;C, -J.;Lu;P, -L.;Lee;Y, -T.;Lee;N, -Y.;Liou;B, -H.;Tang;H, -J.;Lee;M, -H.;Wang;N, -C.;Chen;T, -C.;Hii;I, -M.;Huang;S, -H.;Lin;C, -Y.;Tsai;C, -S.;Cheng;C, -Y.;Hung;C, -C.;Chang;S, -Y.;Huang;Y, -S.;Chen;G, -J.;Wu;P, -Y.;Chen;L, -Y.;Chang;H, -Y.;Liu;W, -C.;Su;Y, -C.;Lin;T, -Y.;Tsai;M, -S.;Lee;Y, -C.;Cheng;S, -H.;Huang;Y, -C.;Peng;A, -T.;Lee;Y, -L.;Lin;C, -C.;Lin;S, -P.;Hsieh;C, -Y.;Wang;H, -W.;Ho;M, -W.;Liu;C, -E.;Hung;T, -C.;Chen;Y, -H.;Lee;C, -Y.;Tsai;H, -C.;Lin;H, -H.;Lee;C, -H. |
| 國立成功大學 |
2024-05-15 |
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus
|
Lin;Kuan-Yin;Sun;Hsin-Yun;Yang;Chia-Jui;Lu;Po-Liang;Lee;Yuan-Ti;Lee;Nan-Yao;Liou;Bo-Huang;Tang;Hung-Jen;Lee;Mei-Hui;Wang;Ning-Chi;Chen;Tun-Chieh;Hii;Ing-Moi;Huang;Sung-Hsi;Lin;Chi-Ying;Tsai;Chin-Shiang;Cheng;Chien-Yu;Hung;Chien-Ching;Hung;Chien-Ching |
| 高雄醫學大學 |
2008 |
Treatment results for children with acute myeloid leukemia inTaiwan
|
梁德成;張泰琮;TPOG團隊 |
| 國立臺灣大學 |
1999 |
Treatment Results of Carcinoma of the Nasal Cavity
|
許智捷; 鍾娜娜; 雷德; 丁禮莉; HSU, CHIH-CHIECH; CHUNG, NA-NA; LUI, LOUIS TAK; TING, LAI-LEI |
| 中國醫藥大學 |
2007-07 |
Treatment Results of Hypopharyngeal Cancer Based on Definitive Radiotherapy
|
陳邦瑜(Pang-Yu Chen); 楊世能(Shih-Neng Yang); 梁基安(Ji-An Liang); 蔡銘修(Ming-Hsui Tsai); 陳尚文(Shang-Wen Chen)*; 林芳仁 |
| 中國醫藥大學 |
2007-07 |
Treatment Results of Hypopharyngeal Cancer Based on Definitive Radiotherapy
|
陳邦瑜(Pang-Yu Chen); 楊世能(Shih-Neng Yang); 梁基安(Ji-An Liang); 蔡銘修(Ming-Hsui Tsai); 陳尚文(Shang-Wen Chen)*; 林芳仁 |
| 國立臺灣大學 |
2000 |
Treatment Results of the Tpog-Nhl92 Protocols for Childhood Non-Hodgkin's Lymphomas in Taiwan: A Report from the Taiwan Pediatric Oncology Group ( Tpog)
|
盧孟佑; LU, MENG-YAO |
| 臺大學術典藏 |
2018-09-10T03:32:24Z |
Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: A report from the Taiwan Pediatric Oncology Group (TPOG)
|
Yang, C.-P.;Hung, I.-J.;Jaing, T.-H.;Lin, K.-H.;Lin, D.-T.;Lu, M.-Y.;Liang, D.-C.;Chen, S.-H.;Liu, H.-C.;Hsiao, C.-C.;Shu, S.-G.;Chen, J.-S.;Chang, T.-T.;Chiou, S.-S.;Hsieh, Y.-L.;Lin, M.-T.;Lee, M.-T.;Peng, C.-T.;Cheng, S.-N.;Chen, R.-L.;Chen, B.-W.;Lin, K.-S.; KAI-HSIN LIN |
| 臺大學術典藏 |
2020-12-16T07:22:10Z |
Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: A report from the Taiwan Pediatric Oncology Group (TPOG)
|
Chen J.-S.; Chang T.-T.; Chiou S.-S.; Hsieh Y.-L.; Lin M.-T.; Lee M.-T.; Peng C.-T.; Cheng S.-N.; Chen R.-L.; Chen B.-W.; Lin K.-S.; Yang C.-P.;Hung I.-J.;Jaing T.-H.;Lin K.-H.;Lin D.-T.;Meng-Yao Lu;Liang D.-C.;Chen S.-H.;Liu H.-C.;Hsiao C.-C.;Shu S.-G.;Chen J.-S.;Chang T.-T.;Chiou S.-S.;Hsieh Y.-L.;Lin M.-T.;Lee M.-T.;Peng C.-T.;Cheng S.-N.;Chen R.-L.;Chen B.-W.;Lin K.-S.; Yang C.-P.; Hung I.-J.; Jaing T.-H.; Lin K.-H.; Lin D.-T.; MENG-YAO LU; Liang D.-C.; Chen S.-H.; Liu H.-C.; Hsiao C.-C.; Shu S.-G. |
| 國立成功大學 |
2023 |
Treatment Retention Rates of 3-monthly Paliperidone Palmitate and Risk Factors Associated with Discontinuation: A Population-based Cohort Study
|
Lin, C.-H.;Lin, H.-L.;Chiang, Chiang C.-L.;Chen, Y.-W.;Liu, Y.-F.;Yang, Yang Y.-K.;Tang, C.-H. |
| 臺大學術典藏 |
2021-09-13T05:41:53Z |
Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders
|
Kaufmann C.N.; LIAN-YU CHEN; Crum R.M.; Mojtabai R. |
| 臺大學術典藏 |
2018-09-10T05:12:48Z |
Treatment strategies for developing class III patients
|
Chang, F.H.F.;Chang, J.Z.C.; JENNY ZWEI-CHIENG CHANG |
| 臺大學術典藏 |
2021-07-07T01:20:32Z |
Treatment strategies for developing class III patients
|
Chang F.H.F.; JENNY ZWEI-CHIENG CHANG |
| 臺大學術典藏 |
2018-06-28T23:19:06Z |
Treatment Strategy for Cr(VI)-Bearing Wastes
|
Lo, Kevin S. L.; Lin, Cheng-Fang; Lo, Kevin S. L.; 林正芳; Rou, Wei; Rou, Wei; Lo, Kevin S. L.; Lin, Cheng-Fang |
| 國立臺灣大學 |
1991-05 |
Treatment Strategy for Cr(VI)-Bearing Wastes
|
林正芳; Rou, Wei; Lo, Kevin S. L.; Lin, Cheng-Fang; Rou, Wei; Lo, Kevin S. L. |
| 國立臺灣大學 |
1992 |
Treatment Strategy for Cr(VI)-Bearing Wastes
|
Lin, C. F.; Rou, W.; 駱尚廉; Lin, C. F.; Rou, W.; Lo, Shang-Lien |
| 臺北醫學大學 |
2002 |
Treatment Strategy for Refractory Schizophrenia---Pharmacokinetic and Pharmacodynamic Interactions Between Clozapine and Fluvoxamine
|
盧孟良 |
| 臺北醫學大學 |
2002 |
Treatment Strategy for Refractory Schizophrenia---Pharmacokinetic and Pharmacodynamic Interactions Between Clozapine and Fluvoxamine
|
盧孟良 |
| 臺北醫學大學 |
2010 |
Treatment Strategy for Refractory Schizophrenia: Drug Interaction between Clozapine and Fluvoxamine
|
盧孟良;黃名琪;陳俊興 |
| 臺北醫學大學 |
2010 |
Treatment Strategy for Refractory Schizophrenia: Drug Interaction between Clozapine and Fluvoxamine
|
盧孟良;黃名琪;陳俊興 |
| 臺北醫學大學 |
2008 |
Treatment strategy for refractory schizophrenia: drug interactions between clozapine and fluvoxamine
|
盧孟良;陳俊興;邱智強;劉興政;黃名琪 |
| 臺北醫學大學 |
2009 |
Treatment strategy for refractory schizophrenia: drug interactions between clozapine and fluvoxamine
|
盧孟良;黃名琪;劉興政;陳俊興 |
| 國立臺灣大學 |
2002 |
Treatment Strategy in the Presence of Drug Resistance: Application of Pharmacokinetics/ Pharmacodynamics of Antimicrobial Agents
|
林慧玲; 張上淳; 何藴芳; 陳文慧; 陳瑞龍; LIN, FE-LIN; CHANG, SHAN-CHWEN; HO, YUNN-FANG; CHEN, WEN-HWEI; CHEN, RUSSEL RHEI- LONG |
| 國立臺灣大學 |
1988-07 |
Treatment Studies on the Water Qualities of Keelung River (I)
|
於幼華; Yu, Yue-Hwa |
| 國立臺灣大學 |
1990-02 |
Treatment Studies on the Water Qualities of Keelung River (II)
|
於幼華; Yu, Yue-Hwa |
| 國立交通大學 |
2019-08-02T02:18:30Z |
Treatment Success with Titratable Thermoplastic Mandibular Advancement Devices for Obstructive Sleep Apnea: A Comparison of Patient Characteristics
|
Wang, Tang-Chuan; Tsou, Yung-An; Wu, Yi-Fan; Huang, Chia-Chang; Lin, Wesley Wen-Yang; Li, Yu-Fen; Chen, Michael Yuan-Chien; Tai, Chih-Jaan; Tsai, Ming-Hsui |
| 中國醫藥大學 |
2006-08 |
Treatment targets for diabetic PD patients- any evidence
|
黃秋錦(Chiu-Ching Huang) |
| 國立臺灣大學 |
2003 |
Treatment time reduction for large thermal lesions by using a multiple 1D ultrasound phased array system
|
Liu, Hao-Li; Chen, Yung-Yaw; Yen, Jia-Yush; Lin, Win-Li |
| 國立臺灣大學 |
2003-12 |
Treatment time reduction for large thermal lesions by using a multiple 1D ultrasound phased array system
|
Liu, HL; Chen, YY; Yen, JY; Lin, Win-Li |
| 臺大學術典藏 |
2018-09-10T04:35:19Z |
Treatment time reduction for large thermal lesions by using a multiple 1D ultrasound phased array system
|
Liu, Hao-Li; Chen, Yung-Yaw; Yen, Jia-Yush; Lin, Win-Li; H. L. Liu, Y. Y. Chen, J. Y. Yen and W. L. Lin; YUNG-YAW CHEN; Liu, Hao-Li; JIA-YUSH YEN; Chen, Yung-Yaw; Yen, Jia-Yush; Lin, Win-Li |
| 臺大學術典藏 |
2020-02-26T09:01:12Z |
Treatment time reduction for large thermal lesions by using a multiple 1D ultrasound phased array system
|
Liu H.-L.;Chen Y.-Y.;Yen J.-Y.;Win-Li Lin; Liu H.-L.; Chen Y.-Y.; Yen J.-Y.; Win-Li Lin |
| 亞洲大學 |
2017 |
Treatment with 17 -Estradiol Reduced Body Weight and the Risk of Cardiovascular Disease in a High-Fat Diet-Induced Animal Model of Obesity
|
Liao, 丁韋仁；Wei-Jen Ting；黃志揚；Chih-yang Huang；Chong-He Jia；Chong-He Jiang；Yueh-Min Lin；Yueh-Min Lin；Li-Chin Chun；Li-Chin Chung；Chia-Yao She；Chia-Yao Shen；Pei-Ying Pai；Pei-Ying Pai；Kuan-Ho Lin；Kuan-Ho Lin；Vijaya Padma；Vijaya Padma Viswanadha；Shih-Chieh L；Shih-Chieh |
| 高雄醫學大學 |
2006 |
TREATMENT WITH A BIOSCAFFOLD TO IMPROVE THE HEALING OF A PATELLAR TENDON DEFECT: SHORT TERM RESULTS IN THE RABBIT MODEL
|
傅尹志;Fisher M, B;Liang, R;Nguyen T, D;Moon D, K;Karaoglu, S;Abramowitch S, D;Woo S, L-Y |
| 國立成功大學 |
2021 |
Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF study
|
Lin, W.-Y.;Chung, F.-P.;Liao, C.-T.;Huang, J.-L.;Liang, H.-W.;Lee, Y.-H.;Lin, P.-L.;Chiou, W.-R.;Hsu, C.-Y.;Chang, H.-Y. |
| 國立成功大學 |
2024-06 |
Treatment with Antihistamines and the Risk of Liver Cancer in Patients with Viral Hepatitis: A Multi-Center Cohort Study
|
Chan;Shu-Yen;Chang;Yushan;Polpichai;Natchaya;Lee;Yuan-Ti;Ma;Kevin, Sheng-Kai |
| 國立成功大學 |
2024-10 |
Treatment with autophagic inhibitors enhances oligonol-induced apoptotic effects in nasopharyngeal carcinoma cells
|
Wu;Yen-Ting;Lin;Cheng-Han;Chiu;Wen-Chin;Hsieh;Tsung-Jen;Chang;Sue-Joan;Chang;Yun-Ching;Lan;Yu-Yan |
| 中山醫學大學 |
2021 |
Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice
|
Korolenko, TA; Dubrovina, NI; Ovsyukova, MV; Bgatova, NP; Tenditnik, MV; Pupyshev, AB; Akopyan, AA; Goncharova, NV; Lin, CL; Zavjalov, EL; Tikhonova, MA; Amstislavskaya, TG |
| 中山醫學大學 |
2017-09-14 |
Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3
|
Wu, Yu-Ling;Chang, Jui-Chih;Lin, Wei-Yong;Li, Chien-Chun;Hsieh, Mingli;Chen, Haw-Wen;Wang, Tsu-Shing;Liu, Chin-San;Liu, Kai-Li |
| 臺北醫學大學 |
2000 |
Treatment with chin cap.
|
林錦榮 |
| 中山醫學大學 |
2007 |
Treatment with cystamine alleviates apoptosis in liver from NZB/W F1 mice
|
Tsai-Ching Hsu; Bor-Show Tzang; Tsai-Ching Hsu |
| 中山醫學大學 |
2008 |
Treatment with cystamine alleviates brain abnormality in NZB/W F1 mice
|
Tsai-Ching Hsu; Bor-Show Tzang |
| 中山醫學大學 |
2008 |
Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice
|
Bor-Show Tzang;Szu-Yi Chiang;Wen-Xian Lai; Chun-Chou Tsai; Jen-Huang Wu;Tsai-Ching Hsu |
| 中山醫學大學 |
2008 |
Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice
|
Tzang, Bor-Show; Chiang, Szu-Yi; Lai, Wen-Xian; Tsai, Chun-Chou; Wu, Jen-Huang; Hsu, Tsai-Ching |
| 中山醫學大學 |
2000 |
Treatment with cytotoxic immunosuppression agents increases urinary excretion of JCV in patients with autoimmune disease.
|
Wang, M; Tsai, RT; Ou, WC; Lin, CK; Tsay, GJ; Chang, H; Chang, D |
